I wonder if the timing of this publication was planned to be so close to the release of DSM-5, but this debut guidance on social phobia (now known as social anxiety disorder) is certainly going to ruffle some feathers. It fuels the discussion about the medicalisation of human personality traits and some will see it [read the full story…]
The majority of studies about depression measure outcomes using a scale such as the Hamilton Depression Rating Scale (PDF), which is a questionnaire that patients complete with a health professional. This new randomised controlled trial by researchers from the Arkin Institute for Mental Health in Amsterdam uses the Hamilton Depression Scale, but is also measures social [read the full story…]
This is an unusual randomised controlled trial conducted by a research team from Arkin Institute for Mental Health in Amsterdam and funded by Eli Lilly. The study measures social functioning as an outcome, as well as the more commonly measured depression symptoms. It aims to find out how much psychotherapy is optimal for depressed people [read the full story…]
The evidence-base for psychodynamic psychotherapy is growing. A meta-analysis by Shedler published in early 2010 showed that the effect sizes for psychodynamic therapy can be as large as for other ’empirically supported treatments’. However, there are fewer high quality studies available that look at the effectiveness of these therapies for young people. This systematic review [read the full story…]
